U.S. Point of Care Infectious Disease Testing Market Report by 2033
Press ReleaseThe U.S. point of care infectious disease testing market size was evaluated at USD 1.9 billion by 2023 and is projected to gain around USD 4.59 billion by 2033 with a CAGR of 9.30% between 2024 and 2033. Key Points By disease, the influenza/flu segment has held a major revenue share of 24.42% in 2023. […]